{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:21:03Z","timestamp":1783488063670,"version":"3.55.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.beem.2017.02.006","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T04:31:00Z","timestamp":1487910660000},"page":"91-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Growth hormone deficiency and human immunodeficiency virus"],"prefix":"10.1016","volume":"31","author":[{"given":"Vincenzo","family":"Rochira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Guaraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2017.02.006_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.02.006_bib2","series-title":"GLOBAL REPORT UNAIDS report on the global AIDS epidemic 2013","first-page":"1","article-title":"Global report UNAIDS report on the global AIDS epidemic 2013","author":"2013 UrotgAe","year":"2013"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2017.02.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1293.2012.01055.x","article-title":"Screening for chronic comorbid diseases in people with HIV: the need for a strategic approach","volume":"14","author":"Peters","year":"2013","journal-title":"HIV Med"},{"key":"10.1016\/j.beem.2017.02.006_bib4","first-page":"518","article-title":"Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome","volume":"17","author":"Sellmeyer","year":"1996","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.02.006_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ecl.2014.06.005","article-title":"Hypogonadism in the HIV-infected man","volume":"43","author":"Rochira","year":"2014","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2017.02.006_bib6","first-page":"245","article-title":"Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex","volume":"6","author":"Krentz","year":"1993","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.beem.2017.02.006_bib7","first-page":"956","article-title":"Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection","volume":"77","author":"Mulligan","year":"1993","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib8","first-page":"1542","article-title":"Effects of chronic growth hormone treatment on energy intake and resting energy metabolism in patients with human immunodeficiency virus-associated wasting\u2013a clinical research center study","volume":"83","author":"Mulligan","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib9","doi-asserted-by":"crossref","first-page":"873","DOI":"10.7326\/0003-4819-125-11-199612010-00002","article-title":"Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group","volume":"125","author":"Schambelan","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.beem.2017.02.006_bib10","first-page":"4028","article-title":"Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome","volume":"81","author":"Heijligenberg","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1089\/aid.1997.13.1243","article-title":"Circadian secretory pattern of growth hormone, insulin-like growth factor type I, cortisol, adrenocorticotropic hormone, thyroid-stimulating hormone, and prolactin during HIV infection","volume":"13","author":"Rondanelli","year":"1997","journal-title":"AIDS Res Hum Retrovir"},{"key":"10.1016\/j.beem.2017.02.006_bib12","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2265.1996.705526.x","article-title":"Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system","volume":"44","author":"Frost","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib13","first-page":"4051","article-title":"Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib14","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jcem.86.8.7731","article-title":"Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors","volume":"86","author":"Clasey","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib15","first-page":"289","article-title":"The growth hormone response to insulin induced hypoglycaemia in anorexia nervosa and control underweight or normal subjects","volume":"5","author":"Brauman","year":"1975","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.beem.2017.02.006_bib16","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11154-013-9245-9","article-title":"Pathophysiology of GHRH-growth hormone-IGF1 axis in HIV\/AIDS","volume":"14","author":"Jain","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.beem.2017.02.006_bib17","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1210\/jc.2008-1019","article-title":"Approach to the human immunodeficiency virus-infected patient with lipodystrophy","volume":"93","author":"Brown","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.beem.2011.04.005","article-title":"The effects of HIV-1 infection on endocrine organs","volume":"25","author":"Brown","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib19","doi-asserted-by":"crossref","first-page":"vii","DOI":"10.1016\/j.beem.2011.04.006","article-title":"Endocrine disease in HIV infection","volume":"25","author":"Samaras","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11102-008-0092-8","article-title":"GH\/GHRH axis in HIV lipodystrophy","volume":"12","author":"Stanley","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.02.006_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.beem.2010.11.001","article-title":"Growth hormone and HIV infection: contribution to disease manifestations and clinical implications","volume":"25","author":"Falutz","year":"2011","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1293.2010.00906.x","article-title":"Growth hormone axis treatments for HIV-associated lipodystrophy: a systematic review of placebo-controlled trials","volume":"12","author":"Sivakumar","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/j.beem.2017.02.006_bib23","first-page":"504","article-title":"Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy","volume":"86","author":"Rietschel","year":"2001","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib24","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJM199810293391806","article-title":"Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor","volume":"339","author":"Carr","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.02.006_bib25","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A\u00a0syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.beem.2017.02.006_bib26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350100600102","article-title":"Antiretroviral therapy and the lipodystrophy syndrome","volume":"6","author":"John","year":"2001","journal-title":"Antivir Ther"},{"key":"10.1016\/j.beem.2017.02.006_bib27","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.beem.2017.02.006_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib29","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2008-0027","article-title":"Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects","volume":"30","author":"Moller","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.02.006_bib30","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nrendo.2013.64","article-title":"The GH\/IGF-1 axis in obesity: pathophysiology and therapeutic considerations","volume":"9","author":"Berryman","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.mce.2009.08.017","article-title":"Obesity, growth hormone and weight loss","volume":"316","author":"Rasmussen","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib32","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/S0140-6736(07)60673-4","article-title":"Hypopituitarism","volume":"369","author":"Schneider","year":"2007","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.beem.2017.02.006_bib33","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1210\/jc.2012-4012","article-title":"Idiopathic adult growth hormone deficiency","volume":"98","author":"Melmed","year":"2013","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib34","doi-asserted-by":"crossref","first-page":"E296","DOI":"10.1152\/ajpendo.00335.2003","article-title":"Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy","volume":"286","author":"Koutkia","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib35","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1210\/jc.2004-1342","article-title":"Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy","volume":"90","author":"Koutkia","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.aids.0000218549.85081.8f","article-title":"Growth hormone secretion among HIV infected patients: effects of gender, race and fat distribution","volume":"20","author":"Koutkia","year":"2006","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.beem.2017.02.006_bib37","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2265.2009.03603.x","article-title":"Relationship of peak growth hormone to cardiovascular parameters, waist circumference, lipids and glucose in HIV-infected patients and healthy adults","volume":"71","author":"Lo","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib38","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1530\/EJE-11-0829","article-title":"GH response to GHRH plus arginine is impaired in lipoatrophic women with human immunodeficiency virus compared with controls","volume":"166","author":"Zirilli","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib39","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/EJE-13-0961","article-title":"Gender differences in GH response to GHRH+ARG in lipodystrophic patients with HIV: a key role for body fat distribution","volume":"170","author":"Brigante","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib40","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s12020-016-1133-0","article-title":"Pituitary growth hormone (GH) secretion is partially rescued in HIV-infected patients with GH deficiency (GHD) compared to hypopituitary patients","volume":"55","author":"Diazzi","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.beem.2017.02.006_bib41","series-title":"Arginine in clinical nutrition","article-title":"Arginine in clinical nutrition","author":"Brigante","year":"2016"},{"key":"10.1016\/j.beem.2017.02.006_bib42","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1530\/eje.0.1340352","article-title":"New approach to the diagnosis of growth hormone deficiency in adults","volume":"134","author":"Ghigo","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib43","first-page":"1615","article-title":"Comparison between insulin-induced hypoglycemia and growth hormone (GH)-releasing hormone + arginine as provocative tests for the diagnosis of GH deficiency in adults","volume":"83","author":"Aimaretti","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib45","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib46","first-page":"6","article-title":"Update on epidemiology, etiology, and diagnosis of adult growth hormone deficiency","volume":"31","author":"Prodam","year":"2008","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.02.006_bib47","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/cen.12839","article-title":"Characteristics and outcomes of Italian patients from the observational, multicentre, hypopituitary control and complications study (HypoCCS) according to tertiles of growth hormone peak concentration following stimulation testing at study entry","volume":"83","author":"Losa","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF03345381","article-title":"Different degrees of GH deficiency evidenced by GHRH+arginine test and IGF-I levels in adults with pituitary disease","volume":"28","author":"Aimaretti","year":"2005","journal-title":"J\u00a0Endocrinol Investigation"},{"key":"10.1016\/j.beem.2017.02.006_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib50","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1530\/eje.0.1490117","article-title":"Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients","volume":"149","author":"Cordido","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib51","series-title":"Growth hormone deficiency in adults: 10 years of KIMS","first-page":"75","article-title":"Aetiology and demography of adult growth hormone deficiency","author":"Goth","year":"2004"},{"key":"10.1016\/j.beem.2017.02.006_bib52","first-page":"21","article-title":"Epidemiology of adult growth hormone deficiency. Prevalence, incidence, mortality and morbidity","volume":"33","author":"Erfurth","year":"2005","journal-title":"Front Horm Res"},{"key":"10.1016\/j.beem.2017.02.006_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/eje.1.02191","article-title":"Incidence of GH deficiency \u2013 a nationwide study","volume":"155","author":"Stochholm","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib54","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib55","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jc.2003-030761","article-title":"Adults with partial growth hormone deficiency have an adverse body composition","volume":"89","author":"Murray","year":"2004","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib56","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1365-2265.2010.03809.x","article-title":"Partial growth hormone deficiency in adults; should we be looking for it?","volume":"73","author":"Shalet","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib57","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1080\/00365540410021162","article-title":"Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy","volume":"36","author":"Andersen","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.beem.2017.02.006_bib58","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/eje.0.1410601","article-title":"Impact of gender and androgen status on IGF-I levels in normal and GH-deficient adults","volume":"141","author":"Fisker","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib59","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1172\/JCI2908","article-title":"Regulatory mechanisms of growth hormone secretion are sexually dimorphic","volume":"102","author":"Jaffe","year":"1998","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.beem.2017.02.006_bib60","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1210\/jc.2004-1450","article-title":"Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests","volume":"90","author":"Qu","year":"2005","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib61","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1210\/jc.2009-1134","article-title":"A\u00a0reappraisal of diagnosing GH deficiency in adults: role of gender, age, waist circumference, and body mass index","volume":"94","author":"Colao","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib62","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2003-030246","article-title":"Sexual dimorphism of growth hormone (GH) regulation in humans: endogenous GH-releasing hormone maintains basal GH in women but not in men","volume":"88","author":"Jessup","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib63","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jcem-42-5-942","article-title":"Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone, and prolactin in man","volume":"42","author":"Wiedemann","year":"1976","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib64","first-page":"2291","article-title":"Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density\u2013a clinical research center study","volume":"80","author":"Wright","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib65","first-page":"1023","article-title":"Demonstration of a lack of racial difference in secretion of growth hormone despite a racial difference in bone mineral density in premenopausal women\u2013a Clinical Research Center study","volume":"81","author":"Wright","year":"1996","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.antiviral.2009.10.016","article-title":"Understanding and managing the adverse effects of antiretroviral therapy","volume":"85","author":"Hawkins","year":"2010","journal-title":"Antivir Res"},{"key":"10.1016\/j.beem.2017.02.006_bib67","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jcem-72-1-51","article-title":"Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man","volume":"72","author":"Veldhuis","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib68","first-page":"3209","article-title":"Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay","volume":"80","author":"Veldhuis","year":"1995","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib69","first-page":"E1108","article-title":"Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults","volume":"272","author":"Vahl","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/j.beem.2017.02.006_bib70","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0026-0495(96)90288-7","article-title":"Effects of acipimox, an antilipolytic drug, on the growth hormone (GH) response to GH-releasing hormone alone or combined with arginine in obesity","volume":"45","author":"Maccario","year":"1996","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.beem.2017.02.006_bib71","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0026-0495(92)90220-5","article-title":"Arginine potentiates but does not restore the blunted growth hormone response to growth hormone-releasing hormone in obesity","volume":"41","author":"Ghigo","year":"1992","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.beem.2017.02.006_bib72","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1210\/jc.2008-1333","article-title":"The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men","volume":"93","author":"Makimura","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib73","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1210\/jcem-67-6-1186","article-title":"Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion","volume":"67","author":"Alba-Roth","year":"1988","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib74","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000125890","article-title":"Arginine reinstates the somatotrope responsiveness to intermittent growth hormone-releasing hormone administration in normal adults","volume":"54","author":"Ghigo","year":"1991","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2017.02.006_bib75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF03348621","article-title":"Effect of acipimox, a lipid lowering drug, on growth hormone (GH) response to GH-releasing hormone in normal subjects","volume":"13","author":"Pontiroli","year":"1990","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.02.006_bib76","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1210\/endo-118-6-2390","article-title":"The effect of glucose and free fatty acids on growth hormone (GH)-releasing factor-mediated GH secretion in rats","volume":"118","author":"Imaki","year":"1986","journal-title":"Endocrinology"},{"key":"10.1016\/j.beem.2017.02.006_bib77","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0026-0495(94)90249-6","article-title":"Interaction of free fatty acids and arginine on growth hormone secretion in man","volume":"43","author":"Maccario","year":"1994","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.beem.2017.02.006_bib78","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000125716","article-title":"Evidence for a direct pituitary inhibition by free fatty acids of in\u00a0vivo growth hormone responses to growth hormone-releasing hormone in the rat","volume":"53","author":"Alvarez","year":"1991","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.beem.2017.02.006_bib79","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","article-title":"Circulating ghrelin levels are decreased in human obesity","volume":"50","author":"Tschop","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.beem.2017.02.006_bib80","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/beem.2002.0213","article-title":"Ghrelin and synthetic GH secretagogues","volume":"16","author":"Arvat","year":"2002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib81","doi-asserted-by":"crossref","first-page":"e28512","DOI":"10.1371\/journal.pone.0028512","article-title":"Premature decline of serum total testosterone in HIV-infected men in the HAART-era","volume":"6","author":"Rochira","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.beem.2017.02.006_bib82","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.300.5.509","article-title":"Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial","volume":"300","author":"Lo","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2017.02.006_bib83","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/andr.310","article-title":"Low testosterone is associated with poor health status in men with human immunodeficiency virus infection: a retrospective study","volume":"3","author":"Rochira","year":"2015","journal-title":"Andrology"},{"key":"10.1016\/j.beem.2017.02.006_bib84","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1210\/jc.2015-3993","article-title":"Dysfunctional subcutaneous fat with reduced Dicer and brown adipose tissue gene expression in HIV-infected patients","volume":"101","author":"Torriani","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib85","first-page":"833","article-title":"Is HIV a model of accelerated or accentuated aging?","volume":"69","author":"Pathai","year":"2014","journal-title":"J\u00a0Gerontol Ser A Biol Sci Med Sci"},{"key":"10.1016\/j.beem.2017.02.006_bib86","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/COH.0000000000000240","article-title":"Immune activation and immune aging in HIV infection","volume":"11","author":"Appay","year":"2016","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/j.beem.2017.02.006_bib87","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1210\/jc.2013-4187","article-title":"Growth hormone should be used only for approved indications","volume":"99","author":"Clemmons","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11102-008-0110-x","article-title":"Diagnosis of adult GH deficiency","volume":"11","author":"Gasco","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2017.02.006_bib89","first-page":"33","article-title":"Hypopituitarism and HIV-infection: a new comorbidity in the HAART era?","volume":"31","author":"Zirilli","year":"2008","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.02.006_bib90","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1471-2334-13-481","article-title":"Acute hypophysitis and hypopituitarism in early syphilitic meningitis in a HIV-infected patient: a case report","volume":"13","author":"Spinner","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.beem.2017.02.006_bib91","first-page":"633","article-title":"Hypopituitarism in a HIV affected patient","volume":"119","author":"Harbeck","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes Off J Ger Soc Endocrinol Ger Diabetes Assoc"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2017.02.006_bib92","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1530\/EJE-09-0328","article-title":"From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum \u2013 a KIMS analysis","volume":"161","author":"Klose","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib93","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/j.1365-2265.2009.03754.x","article-title":"Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness","volume":"73","author":"Murray","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib94","doi-asserted-by":"crossref","first-page":"633","DOI":"10.4330\/wjc.v7.i10.633","article-title":"Cardiovascular disease in human immunodeficiency virus infected patients: a true or perceived risk?","volume":"7","author":"Shahbaz","year":"2015","journal-title":"World J Cardiol"},{"issue":"Suppl. 1","key":"10.1016\/j.beem.2017.02.006_bib95","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.4103\/2230-8210.94250","article-title":"Pathogenesis and treatment of human immunodeficiency virus lipodystrophy","volume":"16","author":"Jain","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib96","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/QCO.0b013e3283420eef","article-title":"Pathogenesis and treatment of HIV lipohypertrophy","volume":"24","author":"Leung","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.beem.2017.02.006_bib97","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ghir.2014.12.005","article-title":"Effects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies","volume":"25","author":"Stanley","year":"2015","journal-title":"Growth Horm IGF Res Off J Growth Horm Res Soc Int IGF Res Soc"},{"key":"10.1016\/j.beem.2017.02.006_bib98","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1530\/EJE-10-0702","article-title":"The effect of GH replacement therapy on different fat compartments: a whole-body magnetic resonance imaging study","volume":"164","author":"Egger","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib99","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-12-0002","article-title":"Hepatic steatosis, GH deficiency and the effects of GH replacement: a Liverpool magnetic resonance spectroscopy study","volume":"166","author":"Gardner","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/EJE-11-0558","article-title":"Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis","volume":"166","author":"Hazem","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib101","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.aids.0000180099.35146.30","article-title":"A\u00a0placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation","volume":"19","author":"Falutz","year":"2005","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.beem.2017.02.006_bib102","doi-asserted-by":"crossref","first-page":"e61160","DOI":"10.1371\/journal.pone.0061160","article-title":"Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial","volume":"8","author":"Glesby","year":"2013","journal-title":"Plos One"},{"key":"10.1016\/j.beem.2017.02.006_bib103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/15284336.2015.1126424","article-title":"Effect of recombinant human growth hormone and rosiglitazone for HIV-associated abdominal fat accumulation on adiponectin and other markers of inflammation","volume":"17","author":"Leung","year":"2016","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.beem.2017.02.006_bib104","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1086\/422725","article-title":"The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study","volume":"39","author":"Lo","year":"2004","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.beem.2017.02.006_bib105","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1001\/jama.2010.989","article-title":"Effects of low-dose growth hormone withdrawal in patients with HIV","volume":"304","author":"Lo","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.beem.2017.02.006_bib106","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.arcmed.2013.06.001","article-title":"In\u00a0vitro and in\u00a0vivo effects of IGF-I on adiposity in HIV-associated metabolic disease: a pilot study","volume":"44","author":"Kim","year":"2013","journal-title":"Archives Med Res"},{"key":"10.1016\/j.beem.2017.02.006_bib107","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/QAD.0b013e32830a5058","article-title":"Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation","volume":"22","author":"Falutz","year":"2008","journal-title":"AIDS Lond Engl"},{"key":"10.1016\/j.beem.2017.02.006_bib108","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1210\/jc.2010-0490","volume":"95","author":"Falutz","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib109","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAI.0b013e3181cbdaff","article-title":"Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension","volume":"53","author":"Falutz","year":"2010","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.beem.2017.02.006_bib110","doi-asserted-by":"crossref","first-page":"e0140358","DOI":"10.1371\/journal.pone.0140358","article-title":"Predictors of treatment response to tesamorelin, a growth hormone-releasing factor analog, in HIV-infected patients with excess abdominal fat","volume":"10","author":"Mangili","year":"2015","journal-title":"Plos One"},{"key":"10.1016\/j.beem.2017.02.006_bib111","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/QAI.0b013e31804a7f68","article-title":"Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy","volume":"45","author":"Grunfeld","year":"2007","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.beem.2017.02.006_bib112","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00126334-200403010-00004","article-title":"Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients","volume":"35","author":"Kotler","year":"2004","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.beem.2017.02.006_bib113","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1468-1293.2009.00775.x","article-title":"Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism","volume":"11","author":"Hansen","year":"2010","journal-title":"HIV Med"},{"key":"10.1016\/j.beem.2017.02.006_bib114","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3851\/IMP2927","article-title":"The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial","volume":"21","author":"Kotler","year":"2016","journal-title":"Antivir Ther"},{"key":"10.1016\/j.beem.2017.02.006_bib115","first-page":"1477","article-title":"Effects of human growth hormone, insulin-like growth factor I, and diet and exercise on body composition of obese postmenopausal women","volume":"83","author":"Thompson","year":"1998","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib116","first-page":"1686","article-title":"Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism","volume":"85","author":"Mauras","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib117","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.1210\/jc.2009-2502","article-title":"Effects of insulin-like growth factor (IGF)-I\/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance","volume":"95","author":"Rao","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.02.006_bib118","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.292.2.210","article-title":"Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial","volume":"292","author":"Koutkia","year":"2004","journal-title":"Jama"},{"key":"10.1016\/j.beem.2017.02.006_bib119","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV","volume":"357","author":"Falutz","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.02.006_bib120","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1530\/EJE-12-0563","article-title":"GH therapy in adult GH deficiency: a review of treatment schedules and the evidence for low starting doses","volume":"168","author":"Gasco","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.02.006_bib121","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ecl.2012.04.014","article-title":"The insulin-like growth factor system in cancer","volume":"41","author":"Weroha","year":"2012","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2017.02.006_bib122","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1097\/QAD.0000000000001112","article-title":"Time trends in cancer incidence in persons living with HIV\/AIDS in the antiretroviral therapy era: 1997\u20132012","volume":"30","author":"Park","year":"2016","journal-title":"AIDS"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:51:57Z","timestamp":1761497517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X17300064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1521690X17300064"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2017.02.006","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone deficiency and human immunodeficiency virus","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2017.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}